Search

Your search keyword '"Lipton, Allan"' showing total 1,001 results
Start Over Author "Lipton, Allan"
1,001 results on '"Lipton, Allan"'

3. Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types

Author

Willumsen, Nicholas, Jensen, Christina, Green, George, Nissen, Neel I., Neely, Jaclyn, Nelson, David M., Pedersen, Rasmus S., Frederiksen, Peder, Chen, Inna M., Boisen, Mogens K., Johansen, Astrid Z., Madsen, Daniel H., Svane, Inge Marie, Lipton, Allan, Leitzel, Kim, Ali, Suhail M., Erler, Janine T., Hurkmans, Daan P., Mathijssen, Ron H. J., Aerts, Joachim, Eslam, Mohammed, George, Jacob, Christiansen, Claus, Bissel, Mina J., and Karsdal, Morten A.

Published
2022
Full Text
View/download PDF

4. Diagnostic delays in breast cancer among young women: An emphasis on healthcare providers

Author

Costa, Luis, primary, Kumar, Rakesh, additional, Villarreal-Garza, Cynthia, additional, Sinha, Saket, additional, Saini, Sunil, additional, Semwal, Jayanti, additional, Saxsena, Vartika, additional, Zamre, Vaishali, additional, Chintamani, Chintamani, additional, Ray, Mukurdipi, additional, Shimizu, Chikako, additional, Gusic, Lejla Hadzikadic, additional, Toi, Masakazu, additional, and Lipton, Allan, additional

Published
2024
Full Text
View/download PDF

5. Beyond October, Beyond Pink: A Year-Round Revelation for Women's Breast Health

Author

Kumar, Rakesh, primary, Mardones, Mabel, additional, Costa, Luis, additional, Saini, Sunil, additional, Villarreal-Garza, Cynthia, additional, Martinez-Cannon, Bertha Alejandra, additional, Manjunath, Geetha, additional, Sinha, Saket, additional, Han, Zhiyong, additional, Arora, Anshika, additional, Ferreira, Ana Magalhães, additional, Larsen, Lorna, additional, Hairabedian, Sabine, additional, Curry, Therese, additional, Borge, Hirondina, additional, Amorim, Gilberto, additional, Shimizu, Chikako, additional, Zamre, Vaishali, additional, Toi, Masakazu, additional, Fisher, Paul B., additional, Clarke, Robert, additional, Lipton, Allan, additional, Martin, Miguel, additional, and Warner, Ellen, additional

Published
2023
Full Text
View/download PDF

6. Cancer and Bone: Historical Perspective

Author

Pancholy, Neha, primary, Woods, Cynthia B., additional, Patel, Urmeel, additional, Shah, Neal, additional, Leitzel, Kim, additional, Ali, Suhail, additional, and Lipton, Allan, additional

Published
2020
Full Text
View/download PDF

7. The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis

Author

Gineyts, Evelyne, Bonnet, Nicolas, Bertholon, Cindy, Millet, Marjorie, Pagnon-Minot, Aurélie, Borel, Olivier, Geraci, Sandra, Bonnelye, Edith, Croset, Martine, Suhail, Ali, Truica, Cristina, Lamparella, Nicholas, Leitzel, Kim, Hartmann, Daniel, Chapurlat, Roland, Lipton, Allan, Garnero, Patrick, Ferrari, Serge, Clézardin, Philippe, and Rousseau, Jean-Charles

Published
2018
Full Text
View/download PDF

9. Supplementary Figures S1 and S2 and Supplementary Tables S1 and S2 from Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents

Author

Lipton, Allan, primary, Smith, Matthew R., primary, Fizazi, Karim, primary, Stopeck, Alison T., primary, Henry, David, primary, Brown, Janet E., primary, Shore, Neal D., primary, Saad, Fred, primary, Spencer, Andrew, primary, Zhu, Li, primary, and Warner, Douglas J., primary

Published
2023
Full Text
View/download PDF

10. Allan Lipton_Conflict of Interest Form from Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents

Author

Lipton, Allan, primary, Smith, Matthew R., primary, Fizazi, Karim, primary, Stopeck, Alison T., primary, Henry, David, primary, Brown, Janet E., primary, Shore, Neal D., primary, Saad, Fred, primary, Spencer, Andrew, primary, Zhu, Li, primary, and Warner, Douglas J., primary

Published
2023
Full Text
View/download PDF

12. Data from Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients

Author

Sperinde, Jeff, primary, Jin, Xueguang, primary, Banerjee, Jayee, primary, Penuel, Elicia, primary, Saha, Anasuya, primary, Diedrich, Gundo, primary, Huang, Weidong, primary, Leitzel, Kim, primary, Weidler, Jodi, primary, Ali, Suhail M., primary, Fuchs, Eva-Maria, primary, Singer, Christian F., primary, Köstler, Wolfgang J., primary, Bates, Michael, primary, Parry, Gordon, primary, Winslow, John, primary, and Lipton, Allan, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Data from Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients

Author

Sperinde, Jeff, primary, Jin, Xueguang, primary, Banerjee, Jayee, primary, Penuel, Elicia, primary, Saha, Anasuya, primary, Diedrich, Gundo, primary, Huang, Weidong, primary, Leitzel, Kim, primary, Weidler, Jodi, primary, Ali, Suhail M., primary, Fuchs, Eva-Maria, primary, Singer, Christian F., primary, Köstler, Wolfgang J., primary, Bates, Michael, primary, Parry, Gordon, primary, Winslow, John, primary, and Lipton, Allan, primary

Published
2023
Full Text
View/download PDF

14. CCR Translation for This Article from Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients

Author

Sperinde, Jeff, primary, Jin, Xueguang, primary, Banerjee, Jayee, primary, Penuel, Elicia, primary, Saha, Anasuya, primary, Diedrich, Gundo, primary, Huang, Weidong, primary, Leitzel, Kim, primary, Weidler, Jodi, primary, Ali, Suhail M., primary, Fuchs, Eva-Maria, primary, Singer, Christian F., primary, Köstler, Wolfgang J., primary, Bates, Michael, primary, Parry, Gordon, primary, Winslow, John, primary, and Lipton, Allan, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figures 1-2, Methods from Lactoferrin–Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes

Author

Ha, Ngoc-Han, primary, Nair, Vasudha S., primary, Reddy, Divijendra Natha Sirigiri, primary, Mudvari, Prakriti, primary, Ohshiro, Kazufumi, primary, Ghanta, Krishna Sumanth, primary, Pakala, Suresh B., primary, Li, Da-Qiang, primary, Costa, Luis, primary, Lipton, Allan, primary, Badwe, Rajendra A., primary, Fuqua, Suzanne, primary, Wallon, Margaretha, primary, Prendergast, George C., primary, and Kumar, Rakesh, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 3 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 2 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 1 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure Legends 1-5 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure 4 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

21. Data from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Methods from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 1 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 5 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table 2 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

Author

Ghosh, Ritwik, primary, Narasanna, Archana, primary, Wang, Shizhen Emily, primary, Liu, Shuying, primary, Chakrabarty, Anindita, primary, Balko, Justin M., primary, González-Angulo, Ana María, primary, Mills, Gordon B., primary, Penuel, Elicia, primary, Winslow, John, primary, Sperinde, Jeff, primary, Dua, Rajiv, primary, Pidaparthi, Sailaja, primary, Mukherjee, Ali, primary, Leitzel, Kim, primary, Kostler, Wolfgang J., primary, Lipton, Allan, primary, Bates, Michael, primary, and Arteaga, Carlos L., primary

Published
2023
Full Text
View/download PDF

26. Data from Lactoferrin–Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes

Author

Ha, Ngoc-Han, primary, Nair, Vasudha S., primary, Reddy, Divijendra Natha Sirigiri, primary, Mudvari, Prakriti, primary, Ohshiro, Kazufumi, primary, Ghanta, Krishna Sumanth, primary, Pakala, Suresh B., primary, Li, Da-Qiang, primary, Costa, Luis, primary, Lipton, Allan, primary, Badwe, Rajendra A., primary, Fuqua, Suzanne, primary, Wallon, Margaretha, primary, Prendergast, George C., primary, and Kumar, Rakesh, primary

Published
2023
Full Text
View/download PDF

29. New Targeted Therapies for Bone Metastases

Author

Lipton, Allan, Costa, Luis, Sieber, Paul, Dougall, William C., Braun, Ada, Ablin, Richard J., Series editor, Jiang, Wen G., Series editor, Vassiliou, Vassilios, editor, Chow, Edward, editor, and Kardamakis, Dimitrios, editor

Published
2014
Full Text
View/download PDF

32. Circulating HER2/neu : Clinical Utility

Author

Lipton, Allan, Demers, Laurence, Leitzel, Kim, Ali, Suhail M., Neumann, Rainer, Price, Christopher P., Carney, Walter P., Teicher, Beverly A., editor, Gasparini, Giampietro, editor, and Hayes, Daniel F., editor

Published
2006
Full Text
View/download PDF

34. Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

Author

Lipton, Allan, Fizazi, Karim, Stopeck, Alison T., Henry, David H., Brown, Janet E., Yardley, Denise A., Richardson, Gary E., Siena, Salvatore, Maroto, Pablo, Clemens, Michael, Bilynskyy, Boris, Charu, Veena, Beuzeboc, Philippe, Rader, Michael, Viniegra, Maria, Saad, Fred, Ke, Chunlei, Braun, Ada, and Jun, Susie

Published
2012
Full Text
View/download PDF

36. Effect of bone metastasis on outcomes in the CCTG BR.34 phase II randomized trial of dual immune checkpoint inhibitor (ICI) treatment with or without chemotherapy in high-risk, stage IVA/B NSCLC.

Author

Leitzel, Kim, primary, Ali, Suhail M., additional, Ding, Keyue, additional, Leighl, Natasha B., additional, Vera Badillo, Francisco Emilio, additional, Gaudreau, Pierre-Olivier, additional, Bradbury, Penelope Ann, additional, Goss, Glenwood D., additional, Shepherd, Lois E., additional, Costa, Luis, additional, Suva, Larry J, additional, Drabick, Joseph J., additional, Ma, Patrick C., additional, Joshi, Monika, additional, Polimera, Hyma Vani, additional, and Lipton, Allan, additional

Published
2022
Full Text
View/download PDF

48. Abstract P5-13-10: Elevated plasma IL-8 predicts for reduced outcomes in CCTG MA.38, a phase 2 randomized trial of palbociclib in ER+/HER2- metastatic breast cancer patients

Author

Polimera, Hyma V, primary, Bhatt, Dhirisha, additional, Shepherd, Lois E, additional, Gelmon, Karen, additional, Joy, Anil A, additional, Parulekar, Wendy R, additional, Joshi, Monika, additional, Ali, Suhail M, additional, Leitzel, Kim, additional, Truica, Cristina, additional, Vasekar, Monali, additional, Drabick, Joseph J, additional, Menon, Harry, additional, Shah, Neal, additional, Maddukuri, Ashok, additional, Moku, Prashanth, additional, Halstead, E. Scott, additional, McKeone, Daniel, additional, Umstead, Todd M, additional, Chen, BE, additional, and Lipton, Allan, additional

Published
2022
Full Text
View/download PDF

49. Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin

Author

Karp, Daniel D., Pollak, Michael N., Cohen, Roger B., Eisenberg, Peter D., Haluska, Paul, Yin, Donghua, Lipton, Allan, Demers, Laurence, Leitzel, Kim, Hixon, Mary L., Terstappen, Leon W., Garland, Linda, Paz-Ares, Luis G., Cardenal, Felipe, Langer, Corey J., and Gualberto, Antonio

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results